| Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer | Nature communications |  | | 2026 | 64 | 37 |
|
| Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer | Science advances | | | 2025 | 95 | 232 |
|
| Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy | Cell | | | 2024 | 1,009 | 417 |
|
| Dynamic single-cell regulomes characterize human peripheral blood innate lymphoid cell subpopulations | iScience | | | 2023 | 164 | 65 |
|
